Search - tctmd.com

Displaying 1 - 20 of 184

Sort: Relevancy | Date

News Daily News

PULSAR: Globe Pulsed-Field Ablation System Performs Well in Paroxysmal AF

Todd Neale

January 27, 2026

News Daily News

FDA Approves Aficamten for Obstructive HCM

L.A. McKeown

December 29, 2025

News Daily News

Year in Review: Pulsed-Field Ablation Again Tops Heart Rhythm News

Todd Neale

December 24, 2025

Presentation TCT 2025

Trans-Femoral Intramyocardial Septal Radiofrequency Ablation (tf-PIMSRA) in Patients with Symptomatic HOCM: Technology Demonstration and Results of the PRIMO Study

Presenter: Yiyuan Huang

October 28, 2025

Presentation TCT 2025

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

Presenter: Jorrian Abadeer

October 28, 2025

Presentation TCT 2025

TCT 565: Survival Outcomes in Patients With and Without Devices who Undergo Alcohol Septal Ablation for HOCM

Presenter: Michael Graf

October 28, 2025

Presentation TCT 2025

TCT 1482: Successful Transcatheter Transseptal Implantation of an Aortic Bioprosthesis Into the Mitral Valve ("Valve-in-MAC") After Alcohol Septal Ablation

Presenter: David Zemanek

October 27, 2025

Presentation TCT 2025

TCT 1322: Alcohol Septal Ablation for MAC-Induced LVOT Obstruction

Presenter: Francisco Alexandrino

October 25, 2025

Presentation TCT 2025

TCT 1320: Deciphering the obstruction- Subaortic membrane causing Aortic stenosis in a 78 years old patient

Presenter: Hasan Ilyas

October 25, 2025

Presentation TCT 2025

TCT 1319: Transcatheter Relief of Obstruction and Regurgitation in HOCM: Case of Combined ASA and MitraClip in a Surgical Ineligible Patient

Presenter: Bhanu Maturi

October 25, 2025

Presentation TCT 2025

TCT 1318: Safety and short term outcome of coiling of septal perforators in patient with hypertrophic obstructive cardiomyopathy

Presenter: Puneet Aggarwal

October 25, 2025

Presentation TCT 2025

Septal Ablation Beyond Hypertrophic Cardiomyopathy: Structural Heart Disease Applications

Presenter: Toby Rogers

October 25, 2025

Presentation TCT 2024

TCT 1241: HOCM-Like Physiology Following Tendyne Mitral Valve Repair

Presenter: Safanah Siddiqui

October 30, 2024

Presentation TCT 2024

TCT 1583: Successful Multidisciplinary Management of Late Presentation of HOCM With Severe Pumonary Hypertension With Multiple Interventional Techniques

Presenter: Sukhdeep Basra

October 30, 2024

Presentation TCT 2024

TCT 1590: Customized Cardiac Care: Percutaneous Valve-in-MAC After Alcohol Septal Ablation

Presenter: Pedro Carrilho Ferreira

October 30, 2024

Presentation TCT 2024

TCT 1572: Navigating Narrow Paths: Valve-in-Valve TMVR in a Narrow LVOT

Presenter: Vijayadithyan Jaganathan

October 30, 2024

Presentation TCT 2024

TCT 1358: Fulminant Acute Hemolytic Anemia Due to Severe LVOT Obstruction After Transcatheter Mitral Valve Ring Implantation

Presenter: Huseyin Arman

October 30, 2024

Presentation TCT 2024

When and How Would I Use Septal Ablation to prevent or treat LVOT Obstruction?

Presenter: Paul Mahoney

October 30, 2024

Presentation TCT 2024

TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy

Presenter: Konstantinos Voudris

October 30, 2024

Presentation TCT 2024

TCT 478: Socioeconomic Disparities in Patients Undergoing Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: A 5-Year National Experience

Presenter: Himaja Dutt Chigurupati

October 27, 2024

Advertisement

PULSAR: Globe Pulsed-Field Ablation System Performs Well in Paroxysmal AF

FDA Approves Aficamten for Obstructive HCM

Year in Review: Pulsed-Field Ablation Again Tops Heart Rhythm News

Trans-Femoral Intramyocardial Septal Radiofrequency Ablation (tf-PIMSRA) in Patients with Symptomatic HOCM: Technology Demonstration and Results of the PRIMO Study

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

TCT 565: Survival Outcomes in Patients With and Without Devices who Undergo Alcohol Septal Ablation for HOCM

TCT 1482: Successful Transcatheter Transseptal Implantation of an Aortic Bioprosthesis Into the Mitral Valve ("Valve-in-MAC") After Alcohol Septal Ablation

TCT 1322: Alcohol Septal Ablation for MAC-Induced LVOT Obstruction

TCT 1320: Deciphering the obstruction- Subaortic membrane causing Aortic stenosis in a 78 years old patient

TCT 1319: Transcatheter Relief of Obstruction and Regurgitation in HOCM: Case of Combined ASA and MitraClip in a Surgical Ineligible Patient

TCT 1318: Safety and short term outcome of coiling of septal perforators in patient with hypertrophic obstructive cardiomyopathy

Septal Ablation Beyond Hypertrophic Cardiomyopathy: Structural Heart Disease Applications

TCT 1241: HOCM-Like Physiology Following Tendyne Mitral Valve Repair

TCT 1583: Successful Multidisciplinary Management of Late Presentation of HOCM With Severe Pumonary Hypertension With Multiple Interventional Techniques

TCT 1590: Customized Cardiac Care: Percutaneous Valve-in-MAC After Alcohol Septal Ablation

TCT 1572: Navigating Narrow Paths: Valve-in-Valve TMVR in a Narrow LVOT

TCT 1358: Fulminant Acute Hemolytic Anemia Due to Severe LVOT Obstruction After Transcatheter Mitral Valve Ring Implantation

When and How Would I Use Septal Ablation to prevent or treat LVOT Obstruction?

TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy

TCT 478: Socioeconomic Disparities in Patients Undergoing Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: A 5-Year National Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content